From silos to policy coherence: tobacco control, unhealthy commodity industries and the commercial determinants of health

Tob Control. 2022 Mar;31(2):322-327. doi: 10.1136/tobaccocontrol-2021-057136.

Abstract

Tobacco control has achieved remarkable successes, underpinned by the distinctive norms codified in Article 5.3 of the WHO Framework Convention on Tobacco Control. Tobacco control's experience in managing conflicts of interest is increasingly recognised as relevant for addressing other non-communicable disease epidemics. At the same time, the wider environmental and social harms of tobacco-and other unhealthy commodity industries-underline the potential for enhanced strategic collaboration across health, development and environmental agendas. Such collaboration is increasingly necessary to address key challenges shared across tobacco control and related policy spheres, including the extent to which the harms of tobacco (and other unhealthy commodities) are underpinned by economic and social inequities. Here we demonstrate the relevance of a commercial determinants of health perspective, both for advancing tobacco control and for linking it with health and development more broadly. This perspective is already evident in many areas of research, policy and advocacy, where innovative approaches support the development of closer links with actors in related fields. We draw on the concepts of policy coordination, coherence and integration to show how tobacco control can advance key strategic goals via information sharing, complementary approaches to common problems and collective action with other related movements. Embrace of a commercial determinants perspective will help in building on tobacco control's successes and reorienting strategies in other sectors to more effectively manage health risks and promote sustainable development.

Keywords: disparities; environment; global health; low/middle income country; tobacco industry.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Health Policy
  • Humans
  • Industry
  • Nicotiana
  • Policy
  • Tobacco Industry*
  • Tobacco Products*